+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Coagulation/Hemostasis Analyzers - Global Market Trajectory & Analytics

  • ID: 4804251
  • Report
  • April 2021
  • Region: Global
  • 278 Pages
  • Global Industry Analysts, Inc
Global Coagulation/Hemostasis Analyzers Market to Reach $7 Billion by 2027

Amid the COVID-19 crisis, the global market for Coagulation/Hemostasis Analyzers estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at a CAGR of 8.7% over the period 2020-2027. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$5.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing Analyzers segment is readjusted to a revised 10.3% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 11.8% CAGR

The Coagulation/Hemostasis Analyzers market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Select Competitors (Total 41 Featured):
  • Alere, Inc.
  • Diagnostica Stago SAS
  • Helena Laboratories, Inc.
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
Frequently Asked Questions about the Global Market for Coagulation/Hemostasis Analyzers

What is the estimated value of the Global Market for Coagulation/Hemostasis Analyzers?

The Global Market for Coagulation/Hemostasis Analyzers was estimated to be valued at $3.9 Billion in 2020.

What is the growth rate of the Global Market for Coagulation/Hemostasis Analyzers?

The growth rate of the Global Market for Coagulation/Hemostasis Analyzers is 8.7%, with an estimated value of $7.0 Billion by 2027.

What is the forecasted size of the Global Market for Coagulation/Hemostasis Analyzers?

The Global Market for Coagulation/Hemostasis Analyzers is estimated to be worth $7.0 Billion by 2027.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • Coagulation/Hemostasis Analyzer: A Prelude
  • Steady Growth Projected for Coagulation/Hemostasis Analyzers Market
  • Established Use Case and Technology Improvements Sustain Market Momentum
  • Impact of Covid-19 and a Looming Global Recession
  • Rising Awareness about Blood Clots as the Root of Major Health Issues Fuels Growth in the Coagulation/Hemostasis Analyzer Market
  • Venous Thromboembolism, a Blood Clot that Starts in a Vein
  • Rising Prevalence of Cardiovascular Diseases and Related Mortality Rates Widen Prospects for Coagulation/Hemostasis Analyzers
  • Exhibit 1: Leading Causes of Mortality Worldwide (2016): Number of Deaths in Thousands by Cause
  • Exhibit 2: Leading Causes of Mortality in Low-Income Countries (2016): Crude Death Rate (per 100,000 Population) by Cause
  • Exhibit 3: Leading Causes of Mortality in High-Income Countries (2016): Crude Death Rate (per 100,000 Population) by Cause
  • Exhibit 4: Global Cardiology and Cardiac Surgery Market: Revenues in US$ Billion for the Years 2019 and 2025
  • Exhibit 5: Global Cardiac Surgery Market (2019): Percentage Breakdown of Revenues by Region
  • Aging Global Population at High Risk of Blood Clots and Cardiac Illnesses: A Primary Driver
  • Exhibit 6: Global 60+ Population by Geographic Region for the Years 2017 and 2050
  • Exhibit 7: Top Countries with Highest Proportion of 60+ Population for the Years 1980, 2017 and 2050
  • Clinical Coagulation Analyzers: The Dominant Segment
  • High Performance Coagulation Stations Gain Traction in Lab-based Hemostasis Analysis
  • POC Coagulation Analyzers Segment Exhibits Fast Paced Growth
  • Fully Automated Coagulometers Come to Fore to Suffice Automation Strategies of Modern Laboratories
  • A Peek into Laboratory Automation Trends Worldwide

III. MARKET ANALYSIS

IV. COMPETITION
  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown